The Free-to-Total Serum Prostate Specific Antigen Ratio for Staging Prostate Carcinoma
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 157 (2), 544-547
- https://doi.org/10.1016/s0022-5347(01)65197-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 menUrology, 1995
- Comparison of Prostate Specific Antigen with Prostate Specific Antigen Density for 3 Clinical ApplicationsJournal of Urology, 1994
- Eliminating the Need for Bilateral Pelvic Lymphadenectomy in Select Patients with Prostate CancerJournal of Urology, 1994
- Alpha1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatc hyperplasiaUrology, 1994
- Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate CancerJournal of Urology, 1993
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993
- The TNM classification of prostate cancerThe Prostate, 1992
- Evaluation of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Untreated Prostatic Carcinoma and Benign Prostatic HyperplasiaScandinavian Journal of Urology and Nephrology, 1991
- Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary studyCancer, 1982